0000842023-12-000008.txt : 20120214
0000842023-12-000008.hdr.sgml : 20120214
20120214142646
ACCESSION NUMBER: 0000842023-12-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120213
FILED AS OF DATE: 20120214
DATE AS OF CHANGE: 20120214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TECHNE CORP /MN/
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 12607817
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2012-02-13
0
0001340652
ChemoCentryx, Inc.
CCXI
0000842023
TECHNE CORP /MN/
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
0
1
0
Common Stock
2012-02-13
4
C
0
4713566
A
4713566
D
Common Stock
2012-02-13
4
C
0
1021490
A
5735056
D
Common Stock
2012-02-13
4
P
0
500000
10
A
6235056
D
Series A Preferred Stock
2012-02-13
4
C
0
5000000
D
Common Stock
2500000
0
D
Series B Preferred Stock
2012-02-13
4
C
0
1946836
D
Common Stock
973418
0
D
Series C Preferred Stock
2012-02-13
4
C
0
1223148
D
Common Stock
611574
0
D
Series D Preferred Stock
2012-02-13
4
C
0
1257149
D
Common Stock
628574
0
D
Convertible Promissory Note
2012-02-13
4
C
0
10214900
D
Common Stock
1021490
0
D
Warrant
20
2012-02-13
4
A
0
150000
0
A
2012-02-13
2022-02-12
Common Stock
150000
150000
D
The Issuer's Preferred Stock, which had no expiration date, automatically converted to Common Stock at the closing of the Issuer's initial public offering ("IPO") on February 13, 2012 at a conversion ratio of one share of Common Stock for every two shares of Preferred Stock rounded down to the next whole number, for no additional consideration.
The principal amount of the Convertible Promissory Note, plus accrued interest, automatically converted upon the closing of the IPO at a conversion price of $10.00 per share.
Thomas E Oland, CEO
2012-02-14